Tatsuya Kinjo Selected Research

Tatsuya Kinjo Research Topics

Disease

6	Neoplasms (Cancer) 11/2020 - 10/2004
5	Carcinogenesis 06/2009 - 10/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2010 - 05/2009
3	Body Weight (Weight, Body) 07/2006 - 10/2004
3	Aberrant Crypt Foci 12/2005 - 10/2004
2	Esophageal Neoplasms (Esophageal Cancer) 07/2014 - 01/2014
2	Hyperplasia 06/2013 - 06/2009
2	Carcinoma (Carcinomatosis) 05/2009 - 07/2006
1	Ischemia 11/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2022
1	Peripheral Arterial Disease 11/2022
1	Malnutrition (Nutritional Deficiencies) 11/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 05/2022
1	Portal Hypertension 11/2020
1	Sclerosing Cholangitis 11/2020
1	Cholangitis 11/2020
1	Ulcerative Colitis 11/2020
1	Colonic Neoplasms (Colon Cancer) 11/2020
1	Fibrosis (Cirrhosis) 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Inflammation (Inflammations) 06/2013
1	Cognitive Dysfunction 11/2009
1	Skin Neoplasms (Skin Cancer) 06/2009
1	Papilloma (Papillomatosis) 05/2009

Drug/Important Bio-Agent (IBA)

4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2013 - 05/2009
3	AzoxymethaneIBA 09/2008 - 07/2006
3	beta CateninIBA 07/2006 - 10/2004
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 12/2005 - 10/2004
3	Dimenhydrinate (DMH)FDA LinkGeneric 12/2005 - 10/2004
2	Desipramine (Pertofrane)FDA LinkGeneric 06/2010 - 12/2009
1	Cilostazol (Pletal)FDA LinkGeneric 11/2022
1	fibrin fragment D (D-dimer)IBA 11/2022
1	omega-Chloroacetophenone (Mace)IBA 11/2022
1	Capsules (Microcapsules)IBA 05/2022
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 07/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014
1	nedaplatinIBA 07/2014
1	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 06/2013
1	Acetazolamide (Diamox)FDA LinkGeneric 11/2009
1	PhytochemicalsIBA 06/2009
1	Ellagic AcidIBA 06/2009
1	Codon (Codons)IBA 06/2009
1	Acetylcysteine (Siran)FDA LinkGeneric 06/2009
1	Ursolic AcidIBA 06/2009
1	LycopeneIBA 06/2009
1	ResveratrolIBA 06/2009
1	Grape Seed ExtractIBA 06/2009
1	anthraceneIBA 06/2009
1	Cyclic NucleotidesIBA 05/2009
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2009
1	Phosphodiesterase 4 InhibitorsIBA 05/2009
1	GlucocorticoidsIBA 05/2009
1	Glucaric AcidIBA 09/2008
1	GlucuronidaseIBA 09/2008
1	saccharolactoneIBA 09/2008
1	AnthraquinonesIBA 12/2006
1	Mitogen-Activated Protein Kinase 3IBA 12/2006
1	Emodin (Archin)IBA 12/2006
1	Messenger RNA (mRNA)IBA 07/2006
1	Dextran SulfateIBA 07/2006
1	1- O- beta- glucosyl- N- 2'- hydroxyarachidoyl- 4,8- sphingadienineIBA 12/2005
1	xanthoneIBA 10/2004
1	mangostinIBA 10/2004
1	Biomarkers (Surrogate Marker)IBA 10/2004
1	milk-derived factorIBA 10/2004
1	Alcian BlueIBA 10/2004
1	MucinsIBA 10/2004

Therapy/Procedure

3	Subcutaneous Injections 07/2006 - 10/2004
2	Esophagectomy 07/2014 - 01/2014
1	Therapeutics 11/2022
1	Liver Transplantation 11/2020
1	Restorative Proctocolectomy 11/2020
1	Stents 11/2020
1	Drug Therapy (Chemotherapy) 07/2014
1	Aftercare (After-Treatment) 11/2009